The Molecular Mechanisms Underlying the Regulation of the Biological Activity of Corticotropin-Releasing Hormone Receptors: Implications for Physiology and Pathophysiology
Top Cited Papers
- 1 May 2006
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 27 (3) , 260-286
- https://doi.org/10.1210/er.2005-0034
Abstract
The CRH receptor (CRH-R) is a member of the secretin family of G protein-coupled receptors. Wide expression of CRH-Rs in the central nervous system and periphery ensures that their cognate agonists, the family of CRH-like peptides, are capable of exerting a wide spectrum of actions that underpin their critical role in integrating the stress response and coordinating the activity of fundamental physiological functions, such as the regulation of the cardiovascular system, energy balance, and homeostasis. Two types of mammal CRH-R exist, CRH-R1 and CRH-R2, each with unique splicing patterns and remarkably distinct pharmacological properties, but similar signaling properties, probably reflecting their distinct and sometimes contrasting biological functions. The regulation of CRH-R expression and activity is not fully elucidated, and we only now begin to fully understand the impact on mammalian pathophysiology. The focus of this review is the current and evolving understanding of the molecular mechanisms controlling CRH-R biological activity and functional flexibility. This shows notable tissue-specific characteristics, highlighted by their ability to couple to distinct G proteins and activate tissue-specific signaling cascades. The type of activating agonist, receptor, and target cell appears to play a major role in determining the overall signaling and biological responses in health and disease.Keywords
This publication has 224 references indexed in Scilit:
- Urocortin 2 induces tyrosine hydroxylase phosphorylation in PC12 cellsBiochemical and Biophysical Research Communications, 2005
- Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotypeneurogenetics, 2004
- Ligand Affinity for Amino-Terminal and Juxtamembrane Domains of the Corticotropin Releasing Factor Type I Receptor: Regulation by G-Protein and Nonpeptide AntagonistsBiochemistry, 2004
- Localization and Characterization of a Short Isoform of the Corticotropin-Releasing Factor Receptor Type 2α (CRF2α-tr) in the Rat BrainBiochemical and Biophysical Research Communications, 2001
- Rapid Agonist-Induced Phosphorylation of the Human CRF Receptor, Type 1: A Potential Mechanism for Homologous DesensitizationBiochemical and Biophysical Research Communications, 2000
- Urocortin, a Newly Identified Corticotropin-Releasing Factor-Related Mammalian Peptide, Stimulates Atrial Natriuretic Peptide and Brain Natriuretic Peptide Secretions from Neonatal Rat CardiomyocytesBiochemical and Biophysical Research Communications, 1998
- Stimulation by Corticotropin-Releasing Factor of Atrial Natriuretic Peptide and Brain Natriuretic Peptide Secretions from Cultured Neonatal Rat CardiomyocytesBiochemical and Biophysical Research Communications, 1996
- Homologous desensitization of human corticotropin-releasing factor, receptor in stable transfected mouse fibroblast cellsBrain Research, 1996
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995
- A Variant of the Human Corticotropin-Releasing Factor (CRF) Receptor: Cloning, Expression, and PharmacologyBiochemical and Biophysical Research Communications, 1994